[Évaluation de la mise en œuvre de la Stratégie antidrogue de l'UE 2005-2012 et plans d'action connexes]
Publication disponible en version électronique sur le site de l'éditeur RAND
Illicit drug use continues to be an important public health and safety concern in Europe. Production, trafficking and dealing in illicit drugs constitute important criminal justice challenges in themselves, and are associated with other criminal activities. The 2005-2012 EU Drugs Strategy (as with previous strategies) was developed to complement and add value to national strategies and approaches while respecting the principles of subsidiarity and proportionality set out in the EU Treaties. The main rationale for its development was that while drugs problems vary across Member States, and are experienced at the local and national level, they are "a global issue that needs to be addressed in a transnational context". RAND Europe undertook an independent evaluation of the current Strategy and its Action Plans, addressing four research objectives:
- To assess barriers and facilitators to the implementation of objectives and priorities at EU and Member State level
- To assess the relevance and influence of the Strategy with respect to national drugs policy and legislation
- To assess possible impact on the drugs situation in the EU
- To identify key aspects and recommendations for future EU Drugs Strategies
- Date de parution: août 2012
- Editeur: RAND Corporation
[Preuve d'actions sensibles à la sexospécificité afin de prévenir et de gérer les blessures et la toxicomanie: Santé des jeunes – une intervention pansociétale]
The WHO Regional Office for Europe supports Member States in improving adolescent health by recommending comprehensive, multisectoral and evidence-informed adolescent health approaches; by delineating the critical contribution of the health sector; by fostering actions towards reducing inequalities; and by addressing gender as a key determinant of adolescent health. This publication aims to support this work in the framework of the European strategy for child and adolescent health and development, and is part of the WHO Regional Office for Europe contribution to the development of a new policy framework for Europe, Health 2020, for which the WHO Regional Office for Europe has been mandated by the 53 Member States.
In most European countries there is amounting evidence on gender differences among adolescents with regard to exposure and vulnerability to injuries and substance abuse, however, preventive policies and programmes remain in many instances gender neutral. Generally, there seems to be an assumption that interventions and programmes will be just as effective for boys as for girls. However evidence shows that gender sensitive interventions are more effective and it is recommended that awareness of gender issues in prevention should be included in professional training and continuing education programs for prevention specialists.
- Date de parution: juillet 2011
- Editeur: Organisation Mondiale de la Santé (OMS) [World Health Organization (WHO)]